Clinical trials · Milwaukee, WI
Recurrent Diffuse Large B-Cell Lymphoma clinical trials in Milwaukee
We’re tracking 5 recruiting recurrent diffuse large b-cell lymphoma studies with a site in or near Milwaukee — including Phase 1 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Milwaukee
- NCT06649812RecruitingPhase 2
Testing a combination targeted therapy (ViPOR) for aggressive B-cell lymphoma
This trial tests a new combination of targeted drugs called ViPOR for people with aggressive B-cell lymphoma that has come back or not responded to previous treatment. The goal is to see if this treatment can help when standard therapies haven't worked.
Milwaukee, WisconsinAges 18 years+ - NCT04792489RecruitingPhase 2
CAR-T cell therapy for aggressive B-cell lymphomas
This trial tests a new CAR-T cell treatment (MB-CART2019.1) for people with certain types of aggressive B-cell non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL) that has come back or not responded to prior treatments. It aims to see if this therapy can help when other options have failed.
Milwaukee, WisconsinAges 18 years+ - NCT05890352RecruitingPhase 2
Add new medicines to standard treatment for returning lymphoma
This Phase 2 study tests whether adding tafasitamab, lenalidomide, tazemetostat, and zanubrutinib (along with standard lymphoma treatment) can improve outcomes in people whose large B-cell lymphoma has returned or not responded. It may help control disease more effectively and improve response duration for eligible patients.
Milwaukee, WisconsinAges 18 years+ - NCT05633615RecruitingPhase 2
Testing new drug options after CAR T for aggressive lymphoma
This Phase 2 study tests whether adding or switching drug treatments after CAR T-cell therapy can improve outcomes for people with certain aggressive lymphomas that have come back or did not respond. It mainly looks at who remains disease-stable/partly improved after CAR T and what treatment approach works best next.
Milwaukee, WisconsinAges 18 years+ - NCT05544968RecruitingPhase 1
CD30-targeted cell treatment for hard-to-treat blood cancers
This Phase 1 trial studies an experimental treatment that targets a marker called CD30 on cancer cells. It is for adults with certain relapsed or refractory CD30-positive blood cancers to see how well the treatment works and what side effects it causes.
Milwaukee, WisconsinAges 18 years+
Hear when a new Recurrent Diffuse Large B-Cell Lymphoma trial opens near Milwaukee, WI
We’ll email you when one opens near Milwaukee, WI — at most once a week, no account needed, unsubscribe anytime.
Recurrent Diffuse Large B-Cell Lymphoma trials in other cities
Where these studies are running near Milwaukee
Institutions with a site for the recruiting recurrent diffuse large b-cell lymphoma studies listed above.
- Froedtert & the Medical College of Wisconsin · 2 studies
- Froedtert and MCW Moorland Reserve Health Center · 2 studies
- Medical College of Wisconsin · 2 studies
- Aurora Cancer Care
- Aurora Cancer Care-Grafton
- Aurora Cancer Care-Kenosha South
- Aurora Cancer Care-Milwaukee West
- Aurora Cancer Care-Racine
What taking part in a recurrent diffuse large b-cell lymphoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting recurrent diffuse large b-cell lymphoma studies in Wisconsin.
Common questions
- Are there recurrent diffuse large b-cell lymphoma clinical trials near Milwaukee?
- Yes. We're currently tracking 5 recruiting recurrent diffuse large b-cell lymphoma studies with a site near Milwaukee, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recurrent diffuse large b-cell lymphoma study near Milwaukee?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Milwaukee to take part?
- Not necessarily. These studies have a site near Milwaukee, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recurrent diffuse large b-cell lymphoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recurrent diffuse large b-cell lymphoma studies open near Milwaukee regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.